Failure of complete bile diversion and oral bile acid therapy in the treatment of homozygous familial hypercholesterolemia.
Two patients with nomozygous familial hypercholesterolemia, refractory to medical therapy, underwent complete bile diversion by common-duct ligation and cholecystostomy, in an attempt to arrest the progression of their xanthomatosis and atherosclerosis by depletion of body cholesterol. Clofibrate was given after operation to one patient, and cholic acid to both, in an effort to enhance further the negative sterol balance. Bile diversion produced an increase of six to eight times in gastrointestinal sterol output, which was not increased further by either clofibrate or cholic acid therapy. Despite a calculated sterol loss of 560 g over 14 months in one patient and 400 g over 10 months in the other, neither plasma cholesterol nor xanthoma size decreased. Continuity of the biliary tree was therefore restored. The data suggest that patients with homozygous familial hypercholesterolemia respond to even massive gastrointestinal sterol depletion with equal increases in sterol synthesis.
D000284:Administration, Oral; D000328:Adult; D001646:Bile; D001647:Bile Acids and Salts / Q000378:metabolism; D002648:Child; D002763:Cholecystectomy; D002784:Cholesterol / Q000097:blood; D002793:Cholic Acids / Q000008:administration & dosage* / Q000627:therapeutic use; D002994:Clofibrate / Q000008:administration & dosage / Q000627:therapeutic use; D003135:Common Bile Duct / Q000601:surgery*; D005260:Female; D006720:Homozygote; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D008026:Ligation; D011182:Postoperative Care
D001647:Bile Acids and Salts; D002793:Cholic Acids; D002784:Cholesterol; D002994:Clofibrate